Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al. Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al. Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al. Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al. Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al. Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al. Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al. Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al. Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al. Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al. Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al. Oct 2024 Lancet Infect Dis Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial Autoren Raadsen MP et al. Sep 2024 Cell Host Microbe The RNA landscape of the human commensal Segatella copri reveals a small RNA essential for gut colonization Autoren El Mouali Y et al. Sep 2024 J Med Chem Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity Autoren Mielniczuk S et al. Aug 2024 Nat Immunol Attenuated effector T cells are linked to control of chronic HBV infection Autoren Heim K et al. Aug 2024 Blood Cancer J B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation Autoren Pfeuffer L et al. Aug 2024 Clin Microbiol Infect How to develop a Controlled Human Infection Model for Clostridioides difficile Autoren Hensen ADO et al. Aug 2024 Euro Surveill Rapid regional mobile laboratory response and genomic monkeypox virus (MPXV) surveillance in seven East African Community partner states, August 2024: preparedness activities for the ongoing outbreak Autoren Gehre F et al. Aug 2024 Dtsch Med Wochenschr [Severe complicated malaria caused by Plasmodium falciparum in a female traveler returning from Zanzibar] Autoren Eggeling J et al. Aug 2024 Nat Immunol A mass cytometry method pairing T cell receptor and differentiation state analysis Autoren Garcia Castillo J et al. Aug 2024 Hum Gene Ther Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies Autoren Araujo AE et al. Aug 2024 Front Immunol Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response Autoren Schughart K et al. Aug 2024 Aliment Pharmacol Ther No value of non-selective beta-blockers after TIPS-insertion Autoren Tiede A et al. Aug 2024 Microbiol Spectr Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria Autoren Lamsfus Calle C et al. Aug 2024 J Am Chem Soc The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding Autoren Ludwig KC et al. Pagination < Zurück Current page 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Feb 2025 J Infect Dis Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014 Autoren Postigo-Hidalgo I et al.
Jan 2025 Epid Bull Vernachlässigte Tropenkrankheiten – Gemeinsam handeln für eine Welt ohne NTDs Autoren Fastenau A et al.
Jan 2025 Liver Int Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta Autoren Lampertico P et al.
Jan 2025 Nat Commun Reverse mutational scanning of SARS-CoV-2spike BA.2.86 identifies epitopescontributing to immune escape frompolyclonal sera Autoren Bdeir N et al.
Jan 2025 Nat Commun The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis Autoren Römpp A et al.
Jan 2025 JHEP Rep Adapted hepatitis C virus clone infects innate immunity deficient mouse hepatocytes with minimal human HCV entry factors Autoren Sheldon JA et al.
Jan 2025 The Lancet Microbe Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial Autoren Heinrich N et al.
Dec 2024 Science Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria Autoren Xie F et al.
Dec 2024 Science Advances Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies Autoren Kumar Nagarathinam et al.
Dec 2024 JAMA Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Autoren Gandhi RT et al.
Nov 2024 ACS Infect Dis In Vivo Activity Profiling of Biosynthetic Darobactin D22 Against Critical Gram-Negative Pathogens Autoren Kany AM et al.
Oct 2024 Lancet Infect Dis Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial Autoren Raadsen MP et al.
Sep 2024 Cell Host Microbe The RNA landscape of the human commensal Segatella copri reveals a small RNA essential for gut colonization Autoren El Mouali Y et al.
Sep 2024 J Med Chem Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity Autoren Mielniczuk S et al.
Aug 2024 Nat Immunol Attenuated effector T cells are linked to control of chronic HBV infection Autoren Heim K et al.
Aug 2024 Blood Cancer J B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation Autoren Pfeuffer L et al.
Aug 2024 Clin Microbiol Infect How to develop a Controlled Human Infection Model for Clostridioides difficile Autoren Hensen ADO et al.
Aug 2024 Euro Surveill Rapid regional mobile laboratory response and genomic monkeypox virus (MPXV) surveillance in seven East African Community partner states, August 2024: preparedness activities for the ongoing outbreak Autoren Gehre F et al.
Aug 2024 Dtsch Med Wochenschr [Severe complicated malaria caused by Plasmodium falciparum in a female traveler returning from Zanzibar] Autoren Eggeling J et al.
Aug 2024 Nat Immunol A mass cytometry method pairing T cell receptor and differentiation state analysis Autoren Garcia Castillo J et al.
Aug 2024 Hum Gene Ther Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies Autoren Araujo AE et al.
Aug 2024 Front Immunol Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response Autoren Schughart K et al.
Aug 2024 Aliment Pharmacol Ther No value of non-selective beta-blockers after TIPS-insertion Autoren Tiede A et al.
Aug 2024 Microbiol Spectr Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malaria Autoren Lamsfus Calle C et al.
Aug 2024 J Am Chem Soc The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding Autoren Ludwig KC et al.
